Published ahead of print on July 9, 2009, doi:10.1164/rccm.200903-0421OC
© 2009 American Thoracic Society doi: 10.1164/rccm.200903-0421OC
Randomized Trial of a Decision Aid for Patients with Cystic Fibrosis Considering Lung Transplantation1 Ottawa Health Research Institute, University of Ottawa, Ottawa, Ontario, Canada; 2 Prince Charles Hospital, Brisbane, Queensland, Australia; 3 McMaster University, Hamilton, Ontario, Canada; 4 Royal Prince Alfred Hospital, Sydney, New South Wales, Australia; 5 Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada; 6 University of Alberta, Edmonton, Alberta, Canada; 7 University of British Columbia, Vancouver, British Columbia, Canada; 8 Sir Charles Gairdner Hospital, Perth, Western Australia, Australia; 9 University of Calgary, Calgary, Alberta, Canada; 10 Capital Health District, Halifax, Nova Scotia, Canada; 11 John Hunter Hospital, Newcastle, New South Wales, Australia; 12 Grand River Hospital, Kitchener, Ontario, Canada; 13 University of Western Ontario, London, Ontario, Canada; and 14 Westmead Hospital, Westmead, New South Wales, Australia Correspondence and requests for reprints should be addressed to Shawn D. Aaron, M.D., Ottawa Hospital, General Campus, 501 Smyth Road, Ottawa, ON, K1H 8L6 Canada. E-mail: saaron{at}ohri.ca Rationale: We developed an evidence-based decision aid for patients with advanced cystic fibrosis considering referral for lung transplantation. Objectives: To prospectively evaluate whether use of the decision aid increased knowledge about the options, improved realistic expectations, and decreased decisional conflict in adult patients.
Methods: We performed a single-blind randomized controlled trial involving 149 adult patients with cystic fibrosis with an FEV1 Measurements and Main Results: The primary end points measured were participants' knowledge, realistic expectations, and decisional conflict evaluated 3 weeks after randomization. Patients randomized to the decision aid had greater knowledge about their options (P < 0.0001) and had more realistic expectations about the benefits and risks of lung transplantation (P < 0.0001) compared with those randomized to usual care. The total decisional conflict score was significantly lower in the decision aid group 3 weeks postrandomization compared with the usual care group (11.6 vs. 20.4; P = 0.0007). Decisions were durable; 88% of patients in the decision aid group and 75% in the usual care group maintained the same choice 12 months after randomization (P = 0.06). Conclusions: Use of a decision aid for patients with cystic fibrosis considering referral for lung transplantation, in addition to usual education and counseling, improves patient knowledge, realistic expectations, decisional conflict, and patient satisfaction. Clinical trial registered with www.clinicaltrials.gov (NCT00345449).
Key Words: cystic fibrosis lung transplantation severe lung disease computerized decision-making tools patient education
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||